UCL study: restoring UNC13A splicing reverses TDP-43-linked synaptic defects
Researchers at University College London used cell models, including shRNA-depleted neuroblastoma cells and iPSC-derived neurons carrying UNC13A risk variants, to study how loss of TDP-43 function disrupts splicing of the UNC13A gene. The team reports that correcting this aberrant splicing restored normal synaptic function that had been impaired by TDP-43 depletion.
GoKawiil's interpretation of the reporting above, not reported fact.
TDP-43 dysfunction and UNC13A mis-splicing are implicated in diseases like ALS and frontotemporal dementia, so demonstrating that splice correction can rescue synaptic defects suggests a potential therapeutic strategy targeting this specific RNA processing defect. This could inform future efforts to develop splice-modulating therapies, though translation from cell models to clinical treatment would require substantial further validation.
- TDP-43 loss disrupts normal splicing of the UNC13A gene, affecting synaptic function
- Correcting UNC13A splice defects rescued synaptic dysfunction in cell models
- Findings point to a possible therapeutic target for TDP-43-related neurodegenerative diseases
Source: nature.com — Keuss, 2026-11-11
Published there as: “<i>UNC13A</i> splice correction rescues synaptic dysfunction induced by TDP-43 loss”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.